NCT02206815View on ClinicalTrials.gov

"Safety of Ticagrelor+ Warfarinin Comparison With Clopidogrel+Aspirin+Warfarin"

PHASE4CompletedINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

September 19, 2014

Primary Completion Date

February 20, 2019

Study Completion Date

February 20, 2019

Conditions
Atrial FibrillationCoronary Artery Disease
Interventions
DRUG

Ticagrelor+Warfarin

Ticagrelor 90mg/bid + Warfarin (maintain INR 2.0-2.5)

DRUG

Clopidogrel+Aspirin+Warfarin

Clopidogrel 75mg/day + Aspirin 100mg/day + Warfarin(maintain INR 2.0-2.5)

Trial Locations (3)

210009

Zhongda Hospital, Nanjing

0516

The forth hospital of Xuzhou, Xuzhou

0511

Jiangbin hospital, Zhenjiang

All Listed Sponsors
collaborator

Zhongda Hospital

OTHER

lead

Genshan Ma

OTHER

NCT02206815 - "Safety of Ticagrelor+ Warfarinin Comparison With Clopidogrel+Aspirin+Warfarin" | Biotech Hunter | Biotech Hunter